EP1660037 - Bibliographic data
Aripiprazole injectable suspension
| Last update | 02/06/2025 |
|---|---|
| Legal status | Invention expirée |
| Origin | Euro-PCT |
| (73) Holder |
OTSUKA PHARMACEUTICAL CO., LTD. Shinagawa Grand Central Tower
2-16-4 Konan
Minato-Ku
108-8242 s
TOKYO
Japon
|
|---|---|
| (72) Inventors |
BROWN, Josiah 400 Wall Street 413
Seattle, Washington 98121
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP04779411.0 |
|---|---|
| (22) Request date | 29/07/2004 |
| (11) Publication number | EP1660037 |
|---|---|
| Publication date | 31/08/2011 |
| (54) Title of the invention | Aripiprazole injectable suspension |
|---|---|
| (51) International classification | A61K 9/10, A61K 31/496, A61K 47/38 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 635221 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | None |
|---|---|
| Last annuity | Annuity: 20 - Payment date 27/06/2023 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2011/3, of 30/09/2011 CESSION - bulletin 2015/47, of 20/11/2015 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 31/08/2011 Constitution de mandataire pour un dossier - Legal date 16/09/2011 Expiration de l'invention - Legal date 30/07/2024 |